PubRank

Giovanni A Fava

Author PubWeight™ 57.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term treatment with antidepressant drugs: the spectacular achievements of propaganda. Psychother Psychosom 2002 2.11
2 The biopsychosocial model thirty years later. Psychother Psychosom 2007 1.68
3 Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom 2004 1.51
4 Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom 2013 1.50
5 Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom 2014 1.46
6 Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychother Psychosom 2013 1.43
7 Unmasking special interest groups: the key to addressing conflicts of interest in medicine. Psychother Psychosom 2010 1.38
8 The biopsychosocial factor. Psychother Psychosom 2011 1.38
9 The concept of recovery in major depression. Psychol Med 2007 1.27
10 The cult of mediocrity. Psychother Psychosom 2005 1.15
11 Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry 2005 1.03
12 Staging of mental disorders: systematic review. Psychother Psychosom 2012 0.98
13 Well-being therapy in school settings: a pilot study. Psychother Psychosom 2006 0.97
14 Role of well-being therapy in achieving a balanced and individualized path to optimal functioning. Clin Psychol Psychother 2012 0.97
15 Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety 2010 0.94
16 Mania associated with venlafaxine discontinuation. Int J Neuropsychopharmacol 2003 0.94
17 Psychosomatic aspects of Cushing's syndrome. Rev Endocr Metab Disord 2010 0.93
18 Well-being therapy for generalized anxiety disorder. J Clin Psychol 2009 0.91
19 School intervention for promoting psychological well-being in adolescence. J Behav Ther Exp Psychiatry 2009 0.91
20 Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) 2007 0.91
21 The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom 2008 0.90
22 Information overload, the patient and the clinician. Psychother Psychosom 2007 0.90
23 The relationship of psychological well-being to distress and personality. Psychother Psychosom 2003 0.88
24 New strategies in the assessment of psychological factors affecting medical conditions. J Pers Assess 2007 0.88
25 A different medicine is possible. Psychother Psychosom 2006 0.87
26 The unifying concept of illness behavior. Psychother Psychosom 2012 0.86
27 Psychosomatic assessment of skin diseases in clinical practice. Psychother Psychosom 2005 0.85
28 Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V. J Affect Disord 2006 0.84
29 Psychological aspects of primary aldosteronism. Psychother Psychosom 2006 0.84
30 Circadian blood pressure patterns and life stress. Psychother Psychosom 2002 0.84
31 Subtyping depression in the medically ill by cluster analysis. J Affect Disord 2011 0.83
32 Issues for DSM-V: psychological factors affecting either identified or feared medical conditions: a solution for somatoform disorders. Am J Psychiatry 2007 0.83
33 Psychological assessment in cardiac rehabilitation. Psychother Psychosom 2003 0.81
34 Psychological assessment of primary aldosteronism: a controlled study. J Clin Endocrinol Metab 2011 0.81
35 Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol (Oxf) 2006 0.81
36 Treatment selection in depression: the role of clinical judgment. Psychiatr Clin North Am 2012 0.81
37 How citation analysis can monitor the progress of research in clinical medicine. Psychother Psychosom 2004 0.81
38 Protective environments and health status: cross-talk between human and animal studies. Neurobiol Aging 2005 0.81
39 Assessing the community prevalence of bipolar spectrum symptoms by the mood disorder questionnaire. Psychother Psychosom 2005 0.80
40 Psychological characterization of demoralization in the setting of heart transplantation. J Clin Psychiatry 2010 0.79
41 Diagnostic criteria for psychosomatic research and somatic symptom disorders. Int Rev Psychiatry 2013 0.79
42 Differential effects of well-being promoting and anxiety-management strategies in a non-clinical school setting. J Anxiety Disord 2010 0.79
43 The clinical factor. Psychother Psychosom 2010 0.79
44 Irritable mood in Italian patients with medical disease. J Nerv Ment Dis 2006 0.78
45 The need for a behavioural science focus in research on mental health and mental disorders. Int J Methods Psychiatr Res 2014 0.78
46 The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature. Psychother Psychosom 2016 0.78
47 Conflict of interest in psychopharmacology: can Dr. Jekyll still control Mr. Hyde? Psychother Psychosom 2003 0.78
48 Family intervention approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. J Clin Psychiatry 2007 0.77
49 Residual symptoms in depression an emerging therapeutic concept. Prog Neuropsychopharmacol Biol Psychiatry 2002 0.77
50 Kellner's emotional inhibition scale: a clinimetric approach to alexithymia research. Psychother Psychosom 2011 0.77
51 Psychosocial approach to endocrine disease. Adv Psychosom Med 2007 0.77
52 The Clinical Interview for Depression: a comprehensive review of studies and clinimetric properties. Psychother Psychosom 2010 0.77
53 Use of the Diagnostic Criteria for Psychosomatic Research (DCPR) in a community sample. Psychosomatics 2006 0.77
54 Modern psychiatric treatment: a tribute to Thomas Detre, MD (1924-2011). Psychother Psychosom 2012 0.76
55 Improving the concept of recovery in endocrine disease by consideration of psychosocial issues. J Clin Endocrinol Metab 2012 0.76
56 Assessing somatization with various diagnostic criteria. Psychosomatics 2009 0.76
57 Development of a new assessment strategy in psychosomatic medicine: the diagnostic criteria for psychosomatic research. Adv Psychosom Med 2007 0.76
58 Assessing psychological factors affecting medical conditions: comparison between different proposals. Gen Hosp Psychiatry 2012 0.76
59 Rehabilitation in endocrine patients: a novel psychosomatic approach. Psychother Psychosom 2007 0.76
60 How long should drug treatment of depression last? Med J Aust 2003 0.75
61 Panic and depression. Am J Psychiatry 2002 0.75
62 Clinical Methodology Matters in Epidemiology: Not All Benzodiazepines Are the Same. Psychother Psychosom 2015 0.75
63 The Journal's Appreciation. Psychother Psychosom 2016 0.75
64 Response to "An Evolutionary Approach to Clinical Pharmacopsychology". Psychother Psychosom 2017 0.75
65 Tolerance to antidepressant treatment may be overcome by ketoconazole. Report of two cases. J Psychiatr Res 2003 0.75
66 Use of the Psychosocial Index: A Sensitive Tool in Research and Practice. Psychother Psychosom 2016 0.75
67 Psychiatric classification in the setting of medical disease: comparing the clinical value of different proposals. J Psychosom Res 2010 0.75
68 Conflict of interest and the credibility of medical journals. Epidemiol Psichiatr Soc 2003 0.75
69 [In Process Citation]. Riv Psichiatr 2015 0.75
70 Preserving intellectual freedom in clinical medicine. Psychother Psychosom 2008 0.75
71 General and specialized medicine and psychiatry. Adv Psychosom Med 2012 0.75
72 [Clinical pharmacopsychology]. Riv Psichiatr 2014 0.75
73 Erratum to "CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders" [Prog. Neuro-Psycol. Biol. Psychiatry, 26, 763 (2002)]. Prog Neuropsychopharmacol Biol Psychiatry 2002 0.75
74 The Journal's Progress. Psychother Psychosom 2014 0.75
75 [Therapeutic factors in depression: new strategies]. Riv Psichiatr 2010 0.75
76 Psychosomatic medicine: a name to keep. Psychother Psychosom 2009 0.75
77 Iatrogenic comorbidity in childhood and adolescence: new insights from the use of antidepressant drugs. CNS Drugs 2014 0.75
78 Statistical alchemy for drug treatment of generalized anxiety disorder: a commentary on the meta-analysis by Baldwin et al. [BMJ 2011;342:d1199]. Psychother Psychosom 2011 0.75
79 Including illness behavior in the assessment of endocrine patients. J Clin Endocrinol Metab 2014 0.75
80 Alternatives to debriefing and modifications to cognitive behavior therapy for posttraumatic stress disorder. Psychother Psychosom 2005 0.75
81 Integration of multiple criteria for psychosomatic assessment of dermatological patients. Psychosomatics 2006 0.75
82 [What are the differences between well-being therapy and anxiety management in the school setting?]. Riv Psichiatr 2011 0.75
83 Meta-analyses and conflict of interest. CNS Drugs 2012 0.75
84 Clinical configuration of cyclothymic disturbances. J Affect Disord 2012 0.75
85 Book Received. Psychother Psychosom 2017 0.75